The availability of medicines in general

In Sweden, medicines on a special list are covered up to a certain degree depending on the overall expenditure on medication of a patient during a twelve month period.

• If the expenditure does not exceed SEK 900 (approx. € 63), the patient covers 100% of the drug costs.
• For expenditure between SEK 901 and SEK 1,700 (approx. € 181), the patient covers 50% of the costs.
• For expenditure between SEK 1,701 and SEK 3,300 (approx. € 351), the patient covers 25% of the costs.
• For expenditure between SEK 3,301 and SEK 4,300 (approx. € 458), the patient covers 10% of the costs.
• Costs above SEK 4,300 are totally covered by the healthcare system. [1]

The availability of Alzheimer treatments

All four anti-dementia drugs are available in Spain and are part of the reimbursement system.

Treatment initiation and continuation is limited to specialists and the reimbursement system requires specialists to carry out an MMSE of patients. Alzheimer Europe was unable to obtain information on the MMSE limits for the reimbursement of the four medicines in question.

There are no restrictions for people living alone or in nursing homes.

[1] European Commission (2006): MISSOC – Mutual information system on social protection : Social protection in the Member States of the European Union, of the European Economic Area and in Switzerland : Comparative tables